Eliminates the four times per day testing requirement to qualify for a CGM device.
Allows for individuals using multiple daily administrations (updated from injections) of any insulin, which helps to provide a coverage pathway for people using inhaled insulins.
Removal of “Medicare-covered” from continuous subcutaneous insulin infusion (CSII) pump criterion language for CGMs
Clarification of coding verification language for products billed as K0554
Revision of 5 minutes for measuring interstitial fluid of glucose content by a CGM devise to 1 minute